Lead Product(s) : AGLE-102
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I
Sponsor : Congressionally Directed Medical Research Programs
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety of Extracellular Vesicles for Burn Wounds
Details : Undisclosed
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Inapplicable
October 14, 2021
Lead Product(s) : AGLE-102
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I
Sponsor : Congressionally Directed Medical Research Programs
Deal Size : Inapplicable
Deal Type : Inapplicable